Additionally, the expression levels of KIR2DL1, KIR2DL3 and KIR2DL4 were significantly higher in AML samples than those in normal samples (p < 0.001; Figure 1D). The gene discussed is KIR2DL4; the disease is acute myeloid leukemia.